Status: current, Defined. Date: 31-May 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 475809011000036117 | Mezavant (mesalazine 1.2 g) modified release tablet, 120 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 475810011000036114 | Mezavant 1.2 g modified release tablet, 120, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mezavant 1.2 g modified release tablet, 120, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Mezavant 1.2 g modified release tablet, 120, blister pack | Is a | Mezavant 1.2 g modified release tablet, 120 | true | Inferred relationship | Some | ||
| Mezavant 1.2 g modified release tablet, 120, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Mezavant 1.2 g modified release tablet, 120, blister pack | has TP | Mezavant | true | Inferred relationship | Some | ||
| Mezavant 1.2 g modified release tablet, 120, blister pack | has TPUU | Mezavant 1.2 g modified release tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR